
Nifty Healthcare Prediction for Monday, 20 July 2026: Healthcare Stocks Track Pharma’s Sharp 1.40 Percent Fall
Nifty Healthcare prediction for Monday 20 July 2026: healthcare stocks tracked Nifty Pharma’s sharp 1.40 percent Friday fall to 25,645.00, the sole major sectoral decliner.
Updated: 17 Jul 2026 • 4:07 pm
Posted by:

Nifty healthcare prediction for monday: Healthcare stocks tracked a sharp Friday decline in the closely related Nifty Pharma index, which fell 1.40 percent to 25,645.00, the sole major sectoral decliner even as the broader market posted its strongest session in weeks, led by IT and banking instead. This nifty healthcare prediction for monday is built on Friday, 10 July 2026’s closing data, the last completed session before markets reopen on Monday, 13 July 2026.
Kunal Singla, Associate Director at Univest, notes that the Nifty Healthcare prediction for Monday reflects a clear and decisive rotation away from defensives, since pharma’s sharp decline came precisely on the day the broader market rallied hardest, confirming money moved specifically out of healthcare and into cyclical, largecap-led names.
Click Here – Get Free Investment Predictions
Market Recap Behind the Nifty healthcare prediction for monday
Nifty Pharma, the closest tracked proxy for the healthcare sector, opened at 25,978.70, touched a high of 25,991.25 and a low of 25,549.25 before closing at 25,645.00, down sharply. This reversed the sector’s earlier two-session gains from Tuesday and Wednesday, confirming Friday’s rotation was a genuine and decisive shift.
Nifty healthcare prediction for monday: Trend and Key Levels
Trend: Bearish Below 25,980
Kunal Singla notes that Nifty Pharma’s own 25,549 support and 25,990 resistance zone serves as the closest available reference for the Nifty Healthcare prediction for Monday, given the substantial constituent overlap between the two indices.
Global Cues for Nifty Healthcare on Monday
Indian equities rallied sharply on Friday, led by IT and banking stocks and gains in Reliance Industries ahead of its Q1 FY27 results, even as crude oil extended its climb for a fifth straight session amid the unresolved Strait of Hormuz crisis. With markets shut over the weekend, this outlook for Monday, 20 July 2026, is built entirely on Friday’s closing data. Healthcare and pharma stocks remain largely insulated from these geopolitical and currency-driven cues, and Friday’s sharp decline looks like a clear rotation shift into cyclicals rather than any change in the sector’s own fundamentals.
Key Triggers in the Nifty healthcare prediction for monday
These triggers dominate the outlook heading into Monday, 13 July 2026:
- Continued rotation into cyclicals: If IT and banking keep leading, healthcare could see further underperformance into the new week.
- US generic pricing developments: Any regulatory or pricing news from the US market remains an added sector-specific catalyst.
- HCL Technologies jumped 2.42 percent to Rs 1,203.90 on Friday, its third straight positive session, completing a full recovery from Tuesday’s post-results crash.
Talk to a SEBI Registered Investment Advisor Before Your Next Trade
Related Sectors to Watch
Healthcare’s sharp reversal is best understood relative to the sectors that led Friday’s rally instead.
Nifty IT: Nifty IT jumped 1.75 percent on Friday, a primary destination for money rotating out of healthcare.
Nifty Private Bank: Nifty Private Bank surged 2.12 percent, another key beneficiary of Friday’s rotation.
Risks to the Nifty healthcare prediction for monday
These factors can invalidate this outlook:
- Continued rotation away from defensives: If cyclicals keep rallying, healthcare could see further relative underperformance.
- US regulatory setback: Any adverse FDA decision would compound the sector’s current weakness.
- Weekend risk-off reversal: Ironically, a market-wide sell-off could benefit healthcare as investors rotate back into defensives.
Download the Univest iOS App or Univest Android App to get daily sector research and SEBI registered analyst views on Univest.
Conclusion
The Nifty Healthcare prediction for Monday, 20 July 2026, is bearish below 25,980, after the sector reversed its earlier gains sharply as money rotated decisively into IT and banking on Friday. Kunal Singla flags Nifty Pharma’s own levels as the closest reference for the Nifty Healthcare prediction for Monday, with a reversal of the current rotation the clearest path back to outperformance.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on the Nifty healthcare prediction for monday
What is the Nifty Healthcare prediction for Monday, 20 July 2026?
Ans. The Nifty Healthcare prediction for Monday, 20 July 2026, is bearish below 25,980. Healthcare stocks tracked Nifty Pharma’s sharp 1.40 percent Friday fall, the sole major sectoral decliner.
Which analyst gave the Nifty Healthcare prediction for Monday?
Ans. Kunal Singla, Associate Director at Univest, has shared the Nifty Healthcare prediction for Monday, tracking it closely against Nifty Pharma given significant constituent overlap.
Why did healthcare fall sharply while the broader market rallied on Friday?
Ans. Healthcare fell 1.40 percent on Friday precisely as the broader market posted its strongest session in weeks, led by IT and banking instead, a clear and decisive rotation away from defensives the Nifty Healthcare prediction for Monday flags as the key theme.
Will the defensive rotation away from healthcare continue?
Ans. The Nifty Healthcare prediction for Monday notes that continued IT and banking sector leadership would likely extend healthcare’s underperformance, while any reversal of Friday’s rotation would be the clearest path back to sector strength.
Recent Articles

ABSL Yield Regular Dividend: NAV Today, Performance Review and Should You Invest?
22 July 2026

ABSL Liquid Direct Weekly IDCW: NAV Today, Performance Review and Should You Invest?
22 July 2026

ABSL Short Term Regular IDCW: NAV Today, Performance Review and Should You Invest?
22 July 2026

ABSL Long Duration Direct IDCW Payout: NAV Today, Performance Review and Should You Invest?
22 July 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
ABSL Yield Regular Dividend: NAV Today, Performance Review and Should You Invest?
ABSL Liquid Direct Weekly IDCW: NAV Today, Performance Review and Should You Invest?
ABSL Short Term Regular IDCW: NAV Today, Performance Review and Should You Invest?
ABSL Long Duration Direct IDCW Payout: NAV Today, Performance Review and Should You Invest?
ABSL Long Duration Regular Growth: NAV Today, Performance Review and Should You Invest?
Popular this week
ABSL Yield Regular Dividend: NAV Today, Performance Review and Should You Invest?
ABSL Liquid Direct Weekly IDCW: NAV Today, Performance Review and Should You Invest?
ABSL Short Term Regular IDCW: NAV Today, Performance Review and Should You Invest?
ABSL Long Duration Direct IDCW Payout: NAV Today, Performance Review and Should You Invest?
ABSL Long Duration Regular Growth: NAV Today, Performance Review and Should You Invest?

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





